title: "Pet negativity"--the new goal of cytoreductive therapy in Hodgkin's lymphoma?
authors.affiliation: Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA. sweetej@ccf.org
authors.forename: John W
authors.initials: JW
authors.lastname: Sweetenham
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006689:Hodgkin Disease / Q000000981:diagnostic imaging* / Q000628:therapy*; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods*; D016879:Salvage Therapy / Q000379:methods*
chemical_list: D019788:Fluorodeoxyglucose F18